Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease
- 20 January 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (2), 138-141
- https://doi.org/10.1161/01.cir.97.2.138
Abstract
Background—Retrospective and case-control studies show that hyperhomocysteinemia is an independent risk factor for atherosclerosis in patients with end-stage renal disease. We studied prospectively...Keywords
This publication has 12 references indexed in Scilit:
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- The oxidant stress of hyperhomocyst(e)inemia.JCI Insight, 1996
- Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.JCI Insight, 1996
- Homocysteine and coronary atherosclerosisJournal of the American College of Cardiology, 1996
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.Proceedings of the National Academy of Sciences, 1994
- Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjectsClinical Chemistry, 1994
- Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular diseaseMetabolism, 1988
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.JCI Insight, 1986